Artificial Intelligence in Cancer is published by Baishideng Publishing Group (BPG). Choosing BPG’s series of journals means placing compliance with scientific norms and ethical standards at the forefront.

 Artificial Intelligence in Cancer is a rigorously peer-reviewed, open-access academic journal dedicated to publishing original, high-quality research findings in the field of cancer, including clinical, translational, and basic studies. The journal focuses on, but is not limited to, the following areas: Bone oncology, breast cancer, gastrointestinal cancer, genitourinary cancer, gynecological cancer, head and neck cancer, hematologic malignancy, lung cancer, lymphoma and myeloma, pediatric oncology, and urologic oncology. Types of articles published by the journal include clinical study, basic study, case report, editorial, review, minireview, systematic review, meta-analysis, guidelines, and correspondence. The journal sincerely welcomes experts and scholars to submit original research manuscripts. Each submission will be peer-reviewed by at least two independent reviewers, who will critically assess its novelty, significance, and reproducibility, as well as any flaws in experimental design and data processing, in order to provide authors with meaningful peer review reports. The journal adheres to editorial policies, peer-review processes, editorial processes, and publication ethics guidelines developed by the editorial office in accordance with the Committee on Publication Ethics, the International Committee of Medical Journal Editors, and the World Association of Medical Editors. These principles form the foundation for delivering high-quality services to authors, providing high-quality academic content to readers, and supporting the advancement of clinical practice. Submit an Article >>

The AIC is now abstracted and indexed in Reference Citation Analysis, China Science and Technology Journal Database.

There is currently no impact factor.

• Cédric Coulouarn, PhD, Senior Researcher, (Email: cedric.coulouarn@inserm.fr) Institut National de la Sante et de la Recherche Medicale, Univ Rennes, Rennes 35033, France

Baishideng Publishing Group (BPG), founded in 1993, is headquartered in California, USA. BPG is committed to editing and publishing high-quality, open-access, peer-reviewed clinical medical journals. Our team comprise the Administrative Office, Editorial Office, Production Department, and New Technology Development Department. Collectively, our principle commitment is to discovery and dissemination of knowledge. Our mission is to provide a high-quality platform for authors to publish innovative research results in the field of clinical, basic, and translational medical research following strict peer review mechanisms. We are guided by our vision to help authors expand their academic influence, provide readers with high-quality academic content, and lead field development. Our values remain strong in adherence to our review guidelines, decision guidelines, and publication ethics, in ensuring the fairness, openness, and transparency of the process from the time of author's submission through each step of first review, peer review, and final review, and in editing and publishing of each high-quality peer-reviewed article.